352 participants
Duration of Androgen Receptor Pathway Inhibitor and ADT With Metastasis Directed Therapy in Oligometastatic Cancer of the Prostate (DIRECT)
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-07-27
- Start Date:
- 2023-05-24
- Completion:
- 2031-02-28
Conditions
- Metastatic Prostate Cancer
Interventions
- DRUG
- OTHER
No Results Yet